KITE-197

· Kite, A Gilead Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KITE-197, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma [Phase 1]